SC Refuses to Halt CIRP Against Rana Kapoor-Linked Bliss Abode, Bliss House: LiveLawBiz
Economy & Nation US Tariff Threat Unlikely To Hurt Indian Pharma Immediately; Consolidation Likely, Says Ind-Ra Moneylife Digital Team 29 July 2026 Proposed tariffs on imported generic pharmaceuticals by US are unlikely to have any immediate negative credit impact on Indian pharmaceuticals companies,… Read the original article here

